Rousettus aegyptiacus (Egyptian rousette): 107506741
Help
Entry
107506741 CDS
T06036
Gene name
PLCG1
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1
KO
K01116
phosphatidylinositol phospholipase C, gamma-1 [EC:
3.1.4.11
]
Organism
ray
Rousettus aegyptiacus (Egyptian rousette)
Pathway
ray00562
Inositol phosphate metabolism
ray01100
Metabolic pathways
ray01521
EGFR tyrosine kinase inhibitor resistance
ray04012
ErbB signaling pathway
ray04014
Ras signaling pathway
ray04015
Rap1 signaling pathway
ray04020
Calcium signaling pathway
ray04062
Chemokine signaling pathway
ray04064
NF-kappa B signaling pathway
ray04066
HIF-1 signaling pathway
ray04070
Phosphatidylinositol signaling system
ray04072
Phospholipase D signaling pathway
ray04360
Axon guidance
ray04370
VEGF signaling pathway
ray04613
Neutrophil extracellular trap formation
ray04650
Natural killer cell mediated cytotoxicity
ray04658
Th1 and Th2 cell differentiation
ray04659
Th17 cell differentiation
ray04660
T cell receptor signaling pathway
ray04664
Fc epsilon RI signaling pathway
ray04666
Fc gamma R-mediated phagocytosis
ray04670
Leukocyte transendothelial migration
ray04722
Neurotrophin signaling pathway
ray04750
Inflammatory mediator regulation of TRP channels
ray04919
Thyroid hormone signaling pathway
ray04933
AGE-RAGE signaling pathway in diabetic complications
ray04935
Growth hormone synthesis, secretion and action
ray05012
Parkinson disease
ray05022
Pathways of neurodegeneration - multiple diseases
ray05135
Yersinia infection
ray05167
Kaposi sarcoma-associated herpesvirus infection
ray05170
Human immunodeficiency virus 1 infection
ray05171
Coronavirus disease - COVID-19
ray05200
Pathways in cancer
ray05205
Proteoglycans in cancer
ray05206
MicroRNAs in cancer
ray05214
Glioma
ray05223
Non-small cell lung cancer
ray05225
Hepatocellular carcinoma
ray05231
Choline metabolism in cancer
ray05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
Module
ray_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
ray00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
107506741 (PLCG1)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
107506741 (PLCG1)
04014 Ras signaling pathway
107506741 (PLCG1)
04015 Rap1 signaling pathway
107506741 (PLCG1)
04370 VEGF signaling pathway
107506741 (PLCG1)
04064 NF-kappa B signaling pathway
107506741 (PLCG1)
04066 HIF-1 signaling pathway
107506741 (PLCG1)
04020 Calcium signaling pathway
107506741 (PLCG1)
04070 Phosphatidylinositol signaling system
107506741 (PLCG1)
04072 Phospholipase D signaling pathway
107506741 (PLCG1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
107506741 (PLCG1)
04650 Natural killer cell mediated cytotoxicity
107506741 (PLCG1)
04660 T cell receptor signaling pathway
107506741 (PLCG1)
04658 Th1 and Th2 cell differentiation
107506741 (PLCG1)
04659 Th17 cell differentiation
107506741 (PLCG1)
04664 Fc epsilon RI signaling pathway
107506741 (PLCG1)
04666 Fc gamma R-mediated phagocytosis
107506741 (PLCG1)
04670 Leukocyte transendothelial migration
107506741 (PLCG1)
04062 Chemokine signaling pathway
107506741 (PLCG1)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
107506741 (PLCG1)
04919 Thyroid hormone signaling pathway
107506741 (PLCG1)
09156 Nervous system
04722 Neurotrophin signaling pathway
107506741 (PLCG1)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
107506741 (PLCG1)
09158 Development and regeneration
04360 Axon guidance
107506741 (PLCG1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
107506741 (PLCG1)
05206 MicroRNAs in cancer
107506741 (PLCG1)
05205 Proteoglycans in cancer
107506741 (PLCG1)
05231 Choline metabolism in cancer
107506741 (PLCG1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
107506741 (PLCG1)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
107506741 (PLCG1)
05214 Glioma
107506741 (PLCG1)
05223 Non-small cell lung cancer
107506741 (PLCG1)
09164 Neurodegenerative disease
05012 Parkinson disease
107506741 (PLCG1)
05022 Pathways of neurodegeneration - multiple diseases
107506741 (PLCG1)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
107506741 (PLCG1)
09171 Infectious disease: bacterial
05135 Yersinia infection
107506741 (PLCG1)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
107506741 (PLCG1)
05171 Coronavirus disease - COVID-19
107506741 (PLCG1)
05167 Kaposi sarcoma-associated herpesvirus infection
107506741 (PLCG1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
107506741 (PLCG1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
ray04131
]
107506741 (PLCG1)
Enzymes [BR:
ray01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
107506741 (PLCG1)
Membrane trafficking [BR:
ray04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
107506741 (PLCG1)
Endocytosis
Macropinocytosis
Phospholipase C
107506741 (PLCG1)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
C2
SH3_1
PH
SH3_9
SH3_2
PH_12
GDPD
PH_9
Motif
Other DBs
NCBI-GeneID:
107506741
NCBI-ProteinID:
XP_015993034
LinkDB
All DBs
Position
Unknown
AA seq
1290 aa
AA seq
DB search
MAGAASPCANGCGPGAPSDAEVLHLCRSLEVGTVMTLFYSKKSQRPERKTFQVKLETRQI
TWSRGADKIEGAIDIREIKEIRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTL
SLQATSEDEVNMWIKGLTWLMEDTLQAATPLQIERWLRKQFYSVDRNREDRISAKDLKNM
LSQVNYRVPNMRFLRERLTDLEQRSSDITYGQFAQLYRSLMYNAQKTMDLPFLEASALRA
GERPELCRVSLPEFQQFLLEYQGELWAVDRLQVQEFMLSFLRDPLREIEEPYFCLDEFVT
FLFSKENSVWNSQLDAVCPDTMHNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMG
CRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLHTIKEHAFVASEYPVILSIEDHCSIA
QQRNMAQYFKKVLGDTLLTKPVDIAADGLPSPSQLKRKILIKHKKLAEGSAYEEVPMSVM
YSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSNDQGNEDEEEPKEASS
STELHSNEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFW
RNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQT
NAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQE
GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNP
GFYVEANPMPTFKCAVKALFDYKAQREDELTFTKSAIIQNVEKQEGGWWRGDYGGKKQLW
FPSNYVEEMVSPAALEPEREHLDENSPLGDLLRGVLDVPACQIAVRPEGKNNRLFVFSIS
MASVQWSLDVAADSQEELQDWVKKIREVAQTADARLTEGKMMERRKKIALELSELVVYCR
PVPFDEEKIGTERACYRDMSSFPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDSS
NYDPLPMWICGSQLVALNFQTPDKPMQMNQALFMTGGHCGYVLQPGTMRDEAFDPFDKSS
LRGLEPCAICIEVLGARHLPKNGRGIVCPFVEIEVAGAEYDSTKQKTEFVVDNGLNPMWP
AKPFHFQISNPEFAFLRFVVYEEDMFSDQNFLAQATFPVKGLKTGYRAVPLKNNYSEDLE
LASLLVKIDIFPAKQENGDLSPFSGMSLRERGSDASGQLFHGRAREGSFEARYQQPFEEF
RISQEHLADHFDSRERRAPRRTRVNGDNRL
NT seq
3873 nt
NT seq
+upstream
nt +downstream
nt
atggcgggcgccgcgtccccctgcgccaatggctgcgggcccggcgcgccctcggacgcc
gaggtgctgcacctctgccgcagcctcgaggtgggcaccgtcatgactttgttctactcc
aagaagtcgcagcggcccgaaaggaagaccttccaggtcaagctggagacgcggcagatc
acgtggagccgtggcgccgacaagatcgaaggggccattgacattcgtgaaatcaaggag
atccgcccagggaagacctcacgagactttgatcgctatcaagaggaccctgctttccga
ccggaccagtcacactgcttcgtcatcctgtatggaatggaattccgcctgaagaccctg
agcttgcaagctacatctgaggatgaagtaaacatgtggatcaagggcttgacttggctg
atggaggatacattgcaagcagctacacccctgcagattgagaggtggctgaggaagcag
ttctactcggtggatcgaaatcgcgaggatcgtatatcagccaaggacctgaagaacatg
ctgtcccaggtcaactaccgagtccccaacatgcgtttcctccgagagcggctgacggac
ctggagcagcgcagcagcgacatcacctatgggcagtttgctcagctgtaccgcagcctc
atgtacaacgcccagaagacgatggacctccccttcttggaagccagtgccctgagggct
ggggagcggccagaactctgccgagtgtctcttcctgagttccagcagttcctcctggag
taccagggggagctatgggctgtcgaccggctccaggtacaggagttcatgctcagcttc
ctccgagaccccttgcgagagattgaggagccctatttctgcctggatgagtttgtcacc
ttcctgttctccaaagagaacagtgtgtggaactcacagctggatgccgtgtgcccggac
accatgcacaaccctctctcccactactggatctcctcctcgcacaatacgtacctgact
ggggaccagttctccagcgagtcgtccttagaagcctatgctcgctgcctgcggatgggc
tgtcgctgcatcgaattggactgctgggatggcccagatgggatgccagtcatttaccat
ggacacaccctgaccaccaagatcaagttctctgacgtcctgcacaccatcaaggagcac
gcctttgtggcctcagagtacccggtcatcctgtctatcgaggaccactgcagcatcgcc
cagcagaggaacatggcccagtacttcaagaaggtgcttggggacacgctcctcaccaag
cccgtggacatcgccgccgacgggctcccttcacccagccagctgaagagaaagatcctt
atcaagcacaagaagctggctgagggcagtgcctacgaggaggtgcctatgtctgtcatg
tactctgagaacgacatcagcaactccatcaagaatggcatcctctacctagaggacccc
gtgaaccatgagtggtatccccactacttcgttctgaccagcagcaagatctactactct
gaggagaccagcaatgatcaaggcaacgaggacgaggaagagcctaaggaggccagcagc
agcacagagctgcactccaacgagaagtggttccacgggaagctcggggcaggacgggac
gggcggcacatcgccgagcgcctgctcaccgagtactgcatcgagaccggggcccctgat
ggctccttcctagtgcgcgagagcgagaccttcgtgggcgactacaccctctcgttctgg
cggaacgggaaagtccaacactgccggattcactcccggcaagatgccgggacccccaag
ttcttcctgacagacaacctcgtcttcgactcactctatgacctcatcacgcactaccag
caagtgcccctgcgctgcaacgaattcgagatgcgcctgtcagaacctgtgccacagacc
aatgcccacgagagcaaggagtggtaccacgcaagcctgaccagagcacaggctgagcac
atgctgatgcgtgtcccccgcgatggggccttcctggtgcggaaacggaatgagcccaac
tcctacgccatctccttccgggctgagggcaagatcaagcattgtcgcgtccagcaggag
ggccagacagtgatgctgggcaactcagagttcgacagcctcgtcgacctcatcagctac
tacgagaagcacccgctgtaccgcaagatgaagctgcgctaccccatcaatgaggaggcg
ctggagaagattggcacagctgagccagactatggggccctgtacgagggacgcaaccct
ggcttctacgtggaggcaaacccgatgccgaccttcaagtgtgcagtcaaagccctcttt
gactacaaggcccaaagagaggacgagctgactttcaccaagagcgccatcatccagaac
gtggagaagcaggagggaggctggtggcggggagactacggcgggaagaagcagctgtgg
ttcccgtctaactacgtggaagagatggtcagcccagcggccctggagcctgagagggag
cacttggacgagaatagccccttgggggacttgctgcgtggggtcttggatgtgccagcg
tgtcagattgccgtccgtcccgagggcaagaacaatcggctcttcgtcttctcgatcagt
atggcatcagtgcagtggtccctggatgtcgctgccgactcacaagaggagctgcaggac
tgggtgaaaaagatccgcgaggtggctcagaccgcagatgccaggctcactgaggggaag
atgatggaacggaggaagaagatcgccctggagctgtctgagctggttgtctactgccgg
cctgttcctttcgatgaagagaagattggcacagaacgtgcctgctaccgcgacatgtcg
tccttcccggaaaccaaggccgagaaatacgtgaacaaggccaaaggcaagaagttcctc
cagtacaaccggctgcagctctcccgcatctacccaaaaggccagcggctagactcttcc
aattatgatcccttgcccatgtggatctgtggcagtcagctggtggccctcaacttccag
accccagacaagcctatgcagatgaaccaggccctcttcatgaccggcgggcactgtggc
tatgtgctgcagcccggcaccatgcgggacgaggcctttgacccctttgataagagcagc
cttcgtgggctagagccatgcgccatctgcatcgaggtgctgggcgcccggcatctgcca
aagaatggccggggcattgtgtgtccctttgtggagattgaagtggctggagctgagtat
gacagcaccaagcagaagacagagtttgtggtggacaatggcttgaaccccatgtggccg
gccaagcccttccacttccagatcagtaaccccgaattcgccttcctgcgcttcgtggta
tatgaagaagacatgtttagtgatcagaacttcctggctcaggctactttcccagtgaaa
ggcctaaagacagggtacagagcggtccctttgaagaacaactacagcgaggacctagag
ttggcctccctgctggtcaagatcgacattttccctgccaagcaggagaacggcgacctc
agccccttcagtgggatgtccctgcgggagcggggctccgatgcctcaggccagctgttc
catggccgggcccgcgaaggctcctttgaagcccgctaccagcagccgtttgaggagttt
cgcatctcccaggagcatcttgcggaccactttgacagtcgggaacgaagggccccacgg
aggactcgggtcaatggagataaccgcctctag
Rousettus aegyptiacus (Egyptian rousette): 107521319
Help
Entry
107521319 CDS
T06036
Gene name
PLCG2
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1
KO
K05859
phosphatidylinositol phospholipase C, gamma-2 [EC:
3.1.4.11
]
Organism
ray
Rousettus aegyptiacus (Egyptian rousette)
Pathway
ray00562
Inositol phosphate metabolism
ray01100
Metabolic pathways
ray01521
EGFR tyrosine kinase inhibitor resistance
ray04012
ErbB signaling pathway
ray04014
Ras signaling pathway
ray04020
Calcium signaling pathway
ray04062
Chemokine signaling pathway
ray04064
NF-kappa B signaling pathway
ray04066
HIF-1 signaling pathway
ray04070
Phosphatidylinositol signaling system
ray04072
Phospholipase D signaling pathway
ray04360
Axon guidance
ray04370
VEGF signaling pathway
ray04380
Osteoclast differentiation
ray04611
Platelet activation
ray04613
Neutrophil extracellular trap formation
ray04625
C-type lectin receptor signaling pathway
ray04650
Natural killer cell mediated cytotoxicity
ray04662
B cell receptor signaling pathway
ray04664
Fc epsilon RI signaling pathway
ray04666
Fc gamma R-mediated phagocytosis
ray04670
Leukocyte transendothelial migration
ray04722
Neurotrophin signaling pathway
ray04750
Inflammatory mediator regulation of TRP channels
ray04919
Thyroid hormone signaling pathway
ray04933
AGE-RAGE signaling pathway in diabetic complications
ray04935
Growth hormone synthesis, secretion and action
ray05167
Kaposi sarcoma-associated herpesvirus infection
ray05169
Epstein-Barr virus infection
ray05170
Human immunodeficiency virus 1 infection
ray05171
Coronavirus disease - COVID-19
ray05200
Pathways in cancer
ray05205
Proteoglycans in cancer
ray05206
MicroRNAs in cancer
ray05214
Glioma
ray05223
Non-small cell lung cancer
ray05225
Hepatocellular carcinoma
Module
ray_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
ray00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
107521319 (PLCG2)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
107521319 (PLCG2)
04014 Ras signaling pathway
107521319 (PLCG2)
04370 VEGF signaling pathway
107521319 (PLCG2)
04064 NF-kappa B signaling pathway
107521319 (PLCG2)
04066 HIF-1 signaling pathway
107521319 (PLCG2)
04020 Calcium signaling pathway
107521319 (PLCG2)
04070 Phosphatidylinositol signaling system
107521319 (PLCG2)
04072 Phospholipase D signaling pathway
107521319 (PLCG2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
107521319 (PLCG2)
04613 Neutrophil extracellular trap formation
107521319 (PLCG2)
04625 C-type lectin receptor signaling pathway
107521319 (PLCG2)
04650 Natural killer cell mediated cytotoxicity
107521319 (PLCG2)
04662 B cell receptor signaling pathway
107521319 (PLCG2)
04664 Fc epsilon RI signaling pathway
107521319 (PLCG2)
04666 Fc gamma R-mediated phagocytosis
107521319 (PLCG2)
04670 Leukocyte transendothelial migration
107521319 (PLCG2)
04062 Chemokine signaling pathway
107521319 (PLCG2)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
107521319 (PLCG2)
04919 Thyroid hormone signaling pathway
107521319 (PLCG2)
09156 Nervous system
04722 Neurotrophin signaling pathway
107521319 (PLCG2)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
107521319 (PLCG2)
09158 Development and regeneration
04360 Axon guidance
107521319 (PLCG2)
04380 Osteoclast differentiation
107521319 (PLCG2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
107521319 (PLCG2)
05206 MicroRNAs in cancer
107521319 (PLCG2)
05205 Proteoglycans in cancer
107521319 (PLCG2)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
107521319 (PLCG2)
05214 Glioma
107521319 (PLCG2)
05223 Non-small cell lung cancer
107521319 (PLCG2)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
107521319 (PLCG2)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
107521319 (PLCG2)
05171 Coronavirus disease - COVID-19
107521319 (PLCG2)
05167 Kaposi sarcoma-associated herpesvirus infection
107521319 (PLCG2)
05169 Epstein-Barr virus infection
107521319 (PLCG2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
107521319 (PLCG2)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
ray04131
]
107521319 (PLCG2)
Enzymes [BR:
ray01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
107521319 (PLCG2)
Membrane trafficking [BR:
ray04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
107521319 (PLCG2)
Endocytosis
Macropinocytosis
Phospholipase C
107521319 (PLCG2)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
SH3_1
C2
SH3_9
PH
SH3_2
PH_12
PH_14
EF-hand_like
GDPD
Motif
Other DBs
NCBI-GeneID:
107521319
NCBI-ProteinID:
XP_016021370
LinkDB
All DBs
Position
Unknown
AA seq
1265 aa
AA seq
DB search
MTTMVNVDTLPEYEKSQIKRALELGTVMTVFSFRKSTPERRTVQVIMETRQVAWSKTADK
IEGFLDIMEIKEIRPGKNSKDFERAKVVRQKEDCCFTILYGSQFVLSTLSLAADSKEDAT
KWLSGLKILHQEAMSASTPTIIESWLRKQIYSVDQTRRNSISLRELKAILPMVNFKVGSA
KFLKDKFVEIGAHKDELSFEQFHLLYKKLMFEQQKSIFDEFKKDSSVFILGNTDRPDASA
VHLHDFQRFLLHEQQELWAQDLNKVRERMTRFIDDTMRETAEPFLFVDEFLTYLFSRENS
IWDEKYDVVDIQDMNNPLSHYWISSSHNTYLTGDQLRSESSTEAYIRCLRMGCRCIELDC
WDGPDGKPIIYHGWTRTTKIKFDDVVQAIKDHAFVTSSFPVILSIEEHCCVEQQRYMARV
FKEVFGDLLLIKPTEASADQLPSPTQLREKIIIKHKKLGPRGDVDVNMEDKKDEHKQQGE
LYMWDSIDQKWTRHYCAIADAKLSFSDDIEQTMEEELPQDTPPTELHFGEKWFHKKVEKR
ISAEKLLQEYCSETGGKDGTFLVRESERFPNDYTLSFWRSGRVQHCRIRSTMEGGVMKYY
LTDNLMFTSIYALIQHYRETHLRCAEFELRLTDPVPNPNPHESKPWYYDGLSRGEAEDML
MRVPRDGAFLIRKREGTDSYAITFRAKGKVKHCRINRDGRHFVLGTSAYFESLVELVSYY
EKHALYRKMKLRYPVTPELLERYNMERDINSLYDVSRMYVDPSEINPSMPQRTVKALYDY
KAKQSDELSFCRGALIHNVSKEPGGWWKGDYGTRIQQYFPSNYVEDISTVDVEELEKQII
EDNPLGSLCRGILDLNTYNVVKAPQGKNQKPFVFILEPKKQGDPPVEFATDKVEELFEWF
HSIREITWKIDTKENNMKYWEKNQSIAIELSDLVVYCKPTSKTKDNLENPDFREIRSFVE
TKADSVVRQKPIDLLKYNLKGLTRVYPKGQRVDSSNYDPFRLWLCGSQMVALNFQTADKY
MQMNQALFSLNGRTGYVLQPESMRTEKYDPMPPESQRKILMTLTVKVLGARHLPKLGRSI
ACPFVEVEICGAEYDNNKFKTTVVNDNGLSPVWAPTQEKVTFEIYDPNLAFLRFVVYEED
MFSDPNFLAHATYPIKGIKSGFRSVPLKNGYSEDIELASLLVFCEMRPVLESEEELYSSC
RQLRRRQEELNNQLFLYDTHQNLRNANRDALVKEFNVNENQLQLYQEKCNRRLREKRVSN
SKFYS
NT seq
3798 nt
NT seq
+upstream
nt +downstream
nt
atgaccaccatggtcaacgtggacacccttccggaatatgagaagagccagatcaagaga
gccctggagctgggcacggtgatgaccgtgttcagcttccgcaagtccaccccggagcgg
aggaccgtccaggtgatcatggagacgcggcaagtggcctggagtaagacggctgacaaa
atcgagggcttcttggatatcatggaaataaaggaaatccgccccgggaagaactccaag
gattttgagcgtgcaaaagtagtccgccagaaggaagactgctgttttaccatcttgtac
ggcagccagttcgtcctcagcacactcagtttagcagctgactctaaggaagatgcaact
aagtggctctctggcttgaagatcttacaccaagaagcgatgagtgcgtccacacccacc
attatcgagagttggctgagaaagcagatttattctgtggatcaaaccaggagaaatagc
atcagcctccgagagttgaaggccatcttgcccatggtcaatttcaaagtagggagtgcc
aagttcctcaaagataagtttgtggaaataggtgcacacaaagatgaactcagctttgaa
cagttccatctcctctataaaaagcttatgtttgaacaacaaaaatcgatttttgatgaa
ttcaaaaaagattcctccgtgttcatcttgggcaacaccgaccggccggatgcctccgct
gtccacctgcacgacttccagcggtttctcttacatgaacagcaggagctctgggctcag
gatctgaacaaagtccgtgagcggatgaccaggttcatcgatgacacgatgagggaaact
gccgagcccttcttgtttgtcgatgagttcctcacatacctgttttcacgggagaacagc
atttgggatgaaaagtatgacgtggtagacatacaggacatgaacaaccccttatcccat
tactggatctcctcatcacataacacgtaccttacaggtgaccagctgcggagcgagtca
tccacggaagcatacattcgctgtctgcgcatgggctgtcgctgcattgagctggactgc
tgggacgggcccgatgggaagcccatcatctaccatggctggacacggaccaccaagatc
aagtttgatgacgtcgtgcaggccatcaaagaccatgcctttgtcacctcaagcttccct
gtgatcctgtccatcgaggagcactgttgcgtggagcagcagcgctacatggccagagtg
ttcaaggaggtgtttggcgacttgctgctgataaagcccacggaggccagtgcagaccag
ctgccctcgcccacgcagctgcgggagaagatcatcatcaagcataagaagctgggcccc
cgaggtgatgtagatgtcaacatggaggacaagaaagatgagcacaagcaacagggtgaa
ctgtacatgtgggattccattgatcagaaatggactaggcactactgcgccattgctgat
gccaagctatccttcagcgacgacattgaacagactatggaagaggagctaccccaggat
acaccccccacagaactgcattttggagagaagtggttccataagaaggtggagaagagg
ataagtgccgagaagctactgcaggaatactgcagcgagacggggggcaaagatgggacc
ttcttggtgcgagagagtgagaggttccccaacgactacaccttgtccttctggcggtct
ggccgggtccagcactgccggatccgctccaccatggagggcggagtcatgaagtactac
ctgactgacaacctcatgttcaccagcatctacgccctcatccagcactaccgtgagacg
cacctacggtgtgccgagttcgagctccggctcaccgaccccgtgcccaaccccaacccc
catgagtcaaagccgtggtactatgatgggctgagccgtggagaagcagaggacatgctg
atgagagttccccgggatggagccttcctcatccggaagcgagaaggtaccgactcctac
gccatcaccttcagggccaagggcaaggtgaagcactgtcgcatcaaccgggatggccgg
cactttgtgctggggacctccgcctactttgagagcctggtggaacttgtcagttactac
gagaagcacgcgctctaccgaaagatgaaactgcgctaccctgtgacccccgagctcctt
gaacgctacaatatggaaagagatataaactccctgtatgatgtcagcagaatgtatgtg
gatcccagtgaaatcaatccttctatgcctcagagaaccgtgaaagctctgtatgactac
aaagccaagcagagtgatgagctgagcttttgccgtggtgctctcattcacaacgtctcc
aaggaacccgggggctggtggaaaggagactacggaaccagaatccagcagtacttcccg
tctaattacgtcgaggacatttcaacagtggatgtggaggagctggagaagcagattatt
gaagacaatcccttagggtctctttgcagaggaatattggatctcaacacctataacgtt
gtgaaagccccacaagggaaaaaccagaagcctttcgtctttatcctggagcccaagaag
cagggtgaccctccggtggagtttgccacagacaaggtggaagagctctttgagtggttt
cacagcattcgggagatcacctggaagattgacaccaaggagaacaacatgaagtactgg
gagaagaaccagtcgattgccatcgagctctcggacctggtcgtctactgcaaaccaacc
agcaagaccaaggacaatttagaaaaccccgacttccgagaaatccgctcctttgtggag
acgaaggctgacagcgtcgtccgacagaaacccattgatctcctgaagtacaatctaaag
ggcctgacccgcgtttacccgaaggggcagagggtggactcctccaactatgatcccttc
cgcctctggctgtgtggctcccaaatggtggcgctcaatttccagacagcagataaatac
atgcagatgaatcaggccttgttttcactcaatgggcggactggctacgtcctacagcct
gagagcatgaggacggagaagtatgaccccatgccgcctgagtcccagcggaagatcctg
atgaccttgacggtcaaggttctcggggctcgacatcttcccaagcttggacgaagtatt
gcgtgtccctttgtggaggtggaaatatgtggagctgaatatgacaacaacaagtttaag
acaacggttgtgaatgacaatggcctaagccctgtttgggctccaacacaggagaaggtg
acatttgaaatttatgacccaaaccttgcatttctgcgctttgtggtgtacgaggaagat
atgttcagtgatcccaacttcctggctcatgctacctaccccattaaaggaatcaaatca
ggatttagatctgttcctctgaagaatgggtacagcgaagacattgaactggcttccctc
ctggttttctgtgagatgcggccagtcctggagagtgaagaggaactgtactcctcctgt
cgccagctgcggaggcggcaagaagagctgaacaaccagctctttctatatgacacacac
cagaacttgcgcaatgccaaccgggatgccctggtgaaagagttcaacgtcaacgagaac
cagctccagctgtatcaggagaagtgcaaccgcaggttaagagagaagagagtcagcaac
agcaagttttactcatag
DBGET
integrated database retrieval system